ScreenerHero
FIEFielmann Group AG Inhaber-Aktien o.N.
XETRA · DE · Healthcare · Medical Instruments & Supplies · fielmann-group.com
41.60EUR-0.48%Mkt Cap: 3.81B $P/E: 17.13

Fielmann Group AG engages in vision care and audiology business in Germany, Switzerland, Austria, Spain, North America, and internationally. The company manufactures and sells visual aids mainly glasses, eyewear frames a…

Industry Peers

Medical Instruments & Supplies
Screen all
ISRG
Intuitive Surgical, Inc.
$142.49BUSDP/E 45.6
EL
EssilorLuxottica Societe anonyme
$80.53BUSDP/E 30.2
BDX
Becton, Dickinson and Company
$51.10BUSDP/E 32.5
MDLN
Medline Inc. Class A Common Stock
$45.62BUSDP/E 42.4
ALC
Alcon AG
$32.71BUSDP/E 55.9
RMD
ResMed Inc.
$33.27BUSDP/E 22.1
WST
West Pharmaceutical Services, Inc.
$24.90BUSDP/E 45.4
DIM
Sartorius Stedim Biotech
$20.62BUSDP/E 64.6
SRT3
Sartorius Aktiengesellschaft
$18.68BUSDP/E 87.6
STMN
Straumann Holding AG
$17.47BUSDP/E 41.6
SRT
Sartorius Aktiengesellschaft
$15.01BUSDP/E 70.4
COLO-B
Coloplast A/S
$14.31BUSDP/E 35.6
SOLV
Solventum Corporation
$15.08BUSDP/E 10.8
COO
The Cooper Companies, Inc.
$14.85BUSDP/E 64.5
BAX
Baxter International Inc.
$13.77BUSD
ALGN
Align Technology, Inc.
$11.58BUSDP/E 28.3
RGEN
Repligen Corporation
$9.95BUSDP/E 241.6
AVTR
Avantor, Inc.
$9.44BUSD
ATR
AptarGroup, Inc.
$8.45BUSDP/E 24.0
YPSN
Ypsomed Holding AG
$6.15BUSDP/E 25.1

Key Statistics

Company
Market Cap3.81B $
Enterprise Value4.57B $
Revenue (TTM)2.66B $
Gross Profit2.12B $
Net Income (TTM)221.45M $
Revenue/Share31.59 USD
Last Price41.60 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees18.2K
CountryDE
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINDE0005772206
Valuation
P/E (Trailing)17.13
P/E (Forward)13.44
PEG3.20
EV/EBITDA9.62
EV/Revenue1.72
P/S1.34
P/B3.34
EPS (TTM)2.44
EPS (Forward)2.90
52W Range
38.7516% of range57.00
52W High57.00 EUR
52W Low38.75 EUR
Profitability
Gross Margin79.94%
Oper. Margin14.84%
EBITDA Margin17.87%
Profit Margin8.37%
ROE20.75%
ROA8.20%
Growth
Revenue Growth1.30%
Earnings Growth1.50%
Cash Flow & Leverage
Operating CF539.12M $
CapEx (TTM)125.86M $
FCF Margin—
FCF Yield—
Net Debt714.53M $
Net Debt/EBITDA1.51
Balance Sheet
Debt/Equity0.90
Current Ratio—
Quick Ratio—
Book Value/Sh11.69 EUR
Cash/Share2.635 EUR
Dividends
Fwd Div Rate1.400 EUR
Trail. Div Rate1.400 EUR
Div. Yield3.35%
5Y Avg Yield2.77%
Payout Ratio47.13%
Ex-Div DateJul 10, 2026
Pay Date—
Splits
Last Split2:1
Split DateAug 22, 2014
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)58.63 EUR
Upside (mean)+40.9%
Target Range50.00 EUR – 68.00 EUR
€50.00+40.9% to mean€68.00
# Analysts8
Ownership
Shares Out.83.96M
Float22.85M
Insiders72.91%
Institutions10.38%
Technical
SMA 5041.93 (-0.8%)
SMA 20042.95 (-3.1%)
Beta0.61
S&P 52W Chg18.16%
Avg Vol (30d)66.31K
Avg Vol (10d)40.41K
Technical Indicators
RSI (14)54.3
MACD-0.0514
MACD Signal-0.1533
MACD Hist.+0.1019
BB Upper42.72 EUR
BB Middle41.11 EUR
BB Lower39.49 EUR
BB Width7.87%
ATR (14)0.7664 EUR
Vol Ratio (20d)0.62x